Truncated EGF receptor

Details Truncated EGF receptor Truncated EGF receptor

2005-09-20

2005-09-20

Andres, Janet (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C435S069100

Reexamination Certificate

active

06946543

ABSTRACT:
The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF-α. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.

REFERENCES:
patent: 5218090 (1993-06-01), Connors
patent: 5708156 (1998-01-01), Ilekis
patent: 2002/0002276 (2002-01-01), Fitzpatrick et al.
patent: 91/03489 (1991-03-01), None
patent: 99/62955 (1999-09-01), None
Maihle et al. Proc. Nat. Acad. Sci. 1991, vol.88, pp. 1825-1829.
Ashkenazi et al. Current Opinion in Immunology 1997, vol. 9, pp. 195-200.
Bishayee, S. (Oct. 2000) “Role of Conformational alteration in the epidermal growth factor receptor (EGFR) function”Biochemical Pharmacology60:1217-1223.
Ekstrand et al. (1992) “Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails”Proc. Natl. Acad. Sci. USA 89:4309-4313.
Kohda et al. (Jan. 1993) “A 40-kDa Epidermal Growth Factor/Transforming Growth Factor α-binding Domain Produced by Limited Proteolysis of the Extracellular Domain of the Epidermal Growth Factor Receptor”The Journal of Biological Chemistry268(3):1976-1981.
Reiter et al. (1996) “A 1.8kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor”Nucleic Acids Research24 4050-4056.
Reiter et al. (Jan. 2001) “Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms”Genomics71:1-20.
Saxon et al. (Oct. 1999) “Mutagenesis Reveals a Role for Epidermal Growth Factor Receptor Extracellular Subdomain IV in Ligand Binding”The Journal of Biological Chemistry274(40):28356-28362.
Voldborg et al. (1997) “Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials”Annals of Oncology8:1197-1206.
Ward et al. (1995) “Insulin and Epidermal Growth Factor Receptors Contain the Csteine Repeat Motif Found in the Tumor Necrosis Factor Receptor”PROTEINS: Structure, Function and Genetics22:141-153.
Elleman, TC et al. (Jul. 2001) “Identification of a Determinant of Epidermal Growth Factor Receptor Ligand-Binding Specificity Using a Truncated, High-Affinity Form of the Ectodomain;”Biochemistry40(30):8930-8939.
Garrett, TPJ et al. (Sep. 2002) “Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor;”Cell110(6):763-773.
Jones, J.T. et al. (Mar. 1999) “Binding Specificites and Affinities of egf Domains for ErbB Receptors;”FEBS Letters447:227-231.
Fitzpatrick, V.D. et al. (Jul. 1998) “Formation of a High Affinity Heregulin Binding Site Using the Soluble Extracellular Domains of ErbB2 with ErbB3 or ErbB4;”FEBS Letters431:102-106.

Affiliated with

Also associated with

Rating

Truncated EGF receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Truncated EGF receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Truncated EGF receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3439738